• Kailian , vice-chairman of Cambridge-based Millennium Pharmaceuticals (nasdaq: MLNM - news - people ), chairs ViaCell's board.

    FORBES: Small Stem Cells Find Big Backers

  • Of all of Millennium's (nasdaq: MLNM - news - people ) unapproved drugs, this one is farthest along.

    FORBES: Millennium's On A Roll

  • Take Millennium Pharmaceuticals (nasdaq: MLNM - news - people ), which makes the multiple myeloma drug Velcade .

    FORBES: Big Pharma Could Hog Biotech's Spotlight

  • Infinity's chief scientist, chemist Julian Adams, also invented Velcade, from Millennium Pharmaceuticals (nasdaq: MLNM - news - people ).

    FORBES: Cancer Drugs A Key In MedImmune Purchase

  • Millennium Pharmaceuticals ( MLNM - news - people ).

    FORBES: Health Care

  • Lander has served on the board of Millennium Pharmaceuticals (nasdaq: MLNM - news - people ) since its inception.

    FORBES: The DNA Of Capitalism

  • Along with Takeda's earlier decision to purchase all of Millennium Pharmaceuticals (nasdaq: MLNM - news - people ), the Cambridge, Mass.

    FORBES: BristolClone: What Took So Long?

  • Millennium Pharmaceuticals (nasdaq: MLNM - news - people), another genetic database firm, has made a series of acquisitions and strategic alliances.

    FORBES: Magazine Article

  • Four, including McKee Foods and Millennium Pharmaceuticals (nasdaq: MLNM - news - people ), ripped out PeopleSoft and replaced it with Workday.

    FORBES: Return of Dave

  • Velcade, from Millennium Pharmaceuticals (nasdaq: MLNM - news - people ), is the first new treatment approved for myeloma in a decade.

    FORBES: Magazine Article

  • Separately, Millennium Pharmaceuticals (nasdaq: MLNM - news - people ) used similar chips in its late-stage clinical studies of its cancer drug, Velcade.

    FORBES: Genomics Revolution Actually Happens

  • Richardson points out that Thalomid, Celgene's follow-up drug Revlimid and Velcade, from Millennium Pharmaceuticals (nasdaq: MLNM - news - people ) of Cambridge, Mass.

    FORBES: Thalomid Fuels Celgene's Rise

  • Cowen 's Yaron Werber , speculated that Millennium (nasdaq: MLNM - news - people ) was applying early with the FDA to boost its stock price.

    FORBES: Magazine Article

  • In 1999, the firm was folded into another Cambridge company, LeukoSite , which was purchased four months later by Millennium (nasdaq: MLNM - news - people ).

    FORBES: Millennium's Short Road For Velcade Approval

  • McClellan credited cooperation between Millennium (nasdaq: MLNM - news - people ), the National Cancer Institute and the FDA for making the new drug available so quickly.

    FORBES: FDA Approves Millennium's Velcade

  • This summer Codon enlisted Craig Muir, the roboticist who industrialized gene-finding at Millennium Pharmaceuticals (nasdaq: MLNM - news - people ), to help build its factory in Cambridge.

    FORBES: Drew Endy aims to reinvent the biotechnology industry.

  • Millennium Pharmaceuticals (nasdaq: MLNM - news - people ) and Abbott, for instance, are already in the early stages of human testing on a gene-derived medicine that helps control appetite.

    FORBES: Magazine Article

  • Late last week, Millennium Pharmaceuticals (nasdaq: MLNM - news - people ) disclosed in a regulatory filing that MLN-02, a treatment for Crohn's disease, was effective in a mid-stage clinical trial.

    FORBES: Genentech's Winning Streak

  • Last year, many analysts doubted that Millennium Pharmaceuticals (nasdaq: MLNM - news - people ) could get its cancer drug approved by the U.S. Food and Drug Administration based on early-stage data.

    FORBES: Magazine Article

  • Yesterday, the Food and Drug Administration granted it fast-track status, which should make it easier for Millennium Pharmaceuticals (nasdaq: MLNM - news - people ) to file all the paperwork necessary for approval.

    FORBES: The Man Behind Millennium's Cancer Drug

  • Other medicines, including multiple myeloma drug Velcade, from Millennium (nasdaq: MLNM - news - people ), and rheumatoid arthritis medicine Enbrel, from Amgen (nasdaq: AMGN - news - people ).

    FORBES: Patenting Gravity?

  • Millennium (nasdaq: MLNM - news - people) wants to be Merck (nyse: MRK - news - people), or at least Bristol-Myers Squibb (nyse: BMY - news - people).

    FORBES: Magazine Article

  • For instance, MIT's Eric Lander founded Millennium Pharmaceuticals (nasdaq: MLNM - news - people ) in 1993, but that didn't stop him from being a major force in the academic effort to map the human genome.

    FORBES: Biotech Topples The Ivory Tower

  • When the data are good enough, the FDA sometimes approves a drug based on these trials, as happened recently with Velcade, a Millennium Pharmaceuticals (nasdaq: MLNM - news - people ) drug that treats multiple myeloma.

    FORBES: Celgene Aims For Fast FDA Approval

  • Erbitux, Millennium Pharmaceuticals ' (nasdaq: MLNM - news - people ) Velcade and Novartis ' (nyse: NVS - news - people ) Gleevec were all approved on what would have been considered early-stage data.

    FORBES: Genentech Hits Another Home Run

  • Millennium Pharmaceuticals (nasdaq: MLNM - news - people ) and Abbott Laboratories (nyse: ABT - news - people ) at one point were co-developing an obesity drug, but that product, MLN4760, apparently was mothballed.

    FORBES: DeCode Finds A Fat Gene

  • "In cancer, when you get on the market with one indication, and you have good clinical data, you get wide use, " Barry Greene , general manager of oncology at Millennium Pharmaceuticals (nasdaq: MLNM - news - people ), noted in May.

    FORBES: InterMune Gets Around The FDA

  • "Clearly RNA interference is a revolution that has emerged in the last few years, " says John Maraganore , who left a job as the top scientist at Millennium Pharmaceuticals (nasdaq: MLNM - news - people ) to become Alnylam's chief executive officer.

    FORBES: Magazine Article

  • The Food and Drug Administration has given record-fast approvals to Novartis ' (nyse: NVS - news - people ) Gleevec and Millennium 's (nasdaq: MLNM - news - people ) Velcade based on relatively early-stage data in these diseases.

    FORBES: Cancer Vaccine Finds A Proving Ground

  • Companies like Millennium Pharmaceuticals (nasdaq: MLNM - news - people ) and Novartis (nyse: NVS - news - people ) have received approval for cancer drugs without proving that they extend survival, but those efforts have involved carefully crafted messages.

    FORBES: Puncturing The ImClone Hype

$firstVoiceSent
- 来自原声例句
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定